OCT‐Derived Index of Plaque Attenuation as a Quantitative Metric for Histological Plaque Vulnerability in Human Coronary Atherosclerosis
Catheterization and Cardiovascular Interventions · 13.07.2026
DOI: 10.1002/ccd.70742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 13.07.2026. Verfasst von Yang Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Plaque, Atherosclerotic, Coronary Artery Disease, Coronary Vessels. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Vulnerable plaque rupture is a major mechanism underlying acute coronary events, but imaging‐based risk assessment using individual plaque features remains limited. The histology‐derived vulnerability index (VI) integrates multiple plaque components and is associated with adverse cardiovascular outcomes but requires ex vivo assessment. Optical coherence tomography (OCT) enables high‐resolution in vivo plaque characterization, and the OCT‐derived index of plaque attenuation (IPA) may provide a quantitative measure of integrated plaque vulnerability. AIMS: This study aimed to determine the association between OCT‐derived IPA and histological VI and to identify the histological plaque components contributing to IPA.
Methods
In 240 coronary blocks from 10 human cadaveric hearts, co‐registered OCT and histology were performed. IPA was calculated from attenuation images. Histology quantified necrotic core, collagen, α‐SMA + area, and macrophages (CD68 + , CD206 + ). Associations were assessed using correlation and multivariable regression.
Results
IPA at a 9 mm −1 threshold (IPA 9 ) correlated with VI ( r = 0.714, p < 0.001) and discriminated high‐VI blocks (AUC = 0.852). CD68 + macrophage area ( β = 17.20, p < 0.001) and necrotic core ( β = 1.39, p = 0.013) predicted higher IPA, whereas collagen and α‐SMA + area were inversely associated. CD206 + areas were not independently related with IPA, but the CD206 + /CD68 + ratio significantly improved IPA model performance (Δ R 2 = 0.023, p = 0.004).
Conclusions
OCT‐derived IPA closely corresponds to histological VI and is primarily driven by necrotic core and pro‐inflammatory macrophage infiltration. IPA may serve as a clinically obtainable quantitative OCT marker for integrated assessment of inflammation‐weighted plaque vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- Department of Cardiology, The Six Medical Center of PLA General Hospital, Beijing, China.
- Department of Anatomy, School of Basic Medical Science, Southern Medical University, Guangzhou, China.
- Medical School of Chinese PLA, Beijing, China.
- School of Medicine, Nankai University, Tianjin, China.
ORCID-Profile: Yundai Chen
Zitieren
APA
Cheng, Y., Zhou, S., Guo, J., Cai, X., Tian, F., Ouyang, J., Wang, M., Chen, J., Wei, S., Xu, G., & Chen, Y. (2026). OCT‐Derived Index of Plaque Attenuation as a Quantitative Metric for Histological Plaque Vulnerability in Human Coronary Atherosclerosis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70742
Vancouver
Cheng Y, Zhou S, Guo J, Cai X, Tian F, Ouyang J, et al. OCT‐Derived Index of Plaque Attenuation as a Quantitative Metric for Histological Plaque Vulnerability in Human Coronary Atherosclerosis. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70742
BibTeX
@article{Cheng2026,
author = {Cheng, Yang and Zhou, Shanshan and Guo, Jun and Cai, Xingxuan and Tian, Feng and Ouyang, Jun and Wang, Mingyi and Chen, Jie and Wei, Simeng and Xu, Guangwei and Chen, Yundai},
title = {OCT‐Derived Index of Plaque Attenuation as a Quantitative Metric for Histological Plaque Vulnerability in Human Coronary Atherosclerosis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70742}
}
EUVIMED